Affected investors can register claims through the investor rights protection platform. On December 12, 2024, Humanwell Healthcare (Group) Co., Ltd. (Stock Code: 600079) announced receiving the "Preliminary Administrative Penalty Notice" from the Hubei Bureau of the China Securities Regulatory Commission.
Attorney Niu Bin from Shanghai Baiyue Law Firm, who has handled numerous securities compensation cases, stated that according to the Securities Law and relevant judicial interpretations, investors who suffered losses due to the company's information disclosure violations are entitled to file compensation claims. With the issuance of the Preliminary Administrative Penalty Notice by the Hubei regulatory bureau, the conditions for filing investor compensation lawsuits against ST Humanwell have been met.
Preliminary Claim Conditions: Investors who purchased ST Humanwell (600079) shares between April 23, 2023 and October 24, 2024, and still held the shares at market close on October 24, 2024, may preliminarily qualify for compensation claims. (Final claim scope subject to court ruling)
Required Claim Materials: 1. Original stock transaction statements (with securities firm branch seal): Must include all transaction records from first purchase to printing date, showing remaining holdings if still possessed. 2. Copy of investor's ID card (both sides). 3. Securities account verification statement: Document showing account information issued by the securities firm branch.
Attorney Niu Bin's statement: The above claim conditions are preliminary based on the regulatory notice and don't constitute investment advice or claim outcome guarantees. Final conditions may adjust based on regulatory decisions and court rulings.
(Note: Attorney Niu Bin has 24 years' experience specializing in securities litigation and investor rights protection, having successfully handled hundreds of investor compensation cases.)
Comments